Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT (Q37429216)
Jump to navigation
Jump to search
scientific article published on 31 August 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT |
scientific article published on 31 August 2009 |
Statements
1 reference
Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT (English)
1 reference
Piero Ruggenenti
1 reference
Fabio Pellegrini
1 reference
Roberto Trevisan
1 reference
Nicola Motterlini
1 reference
BENEDICT Study Group
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference